Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?

Leuk Lymphoma. 2010 Mar;51(3):549-51. doi: 10.3109/10428190903515200.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Anemia, Refractory, with Excess of Blasts / complications
  • Anemia, Refractory, with Excess of Blasts / drug therapy*
  • Cytogenetics
  • Female
  • Humans
  • Karyotyping
  • Male
  • Melphalan / therapeutic use*
  • Middle Aged
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / drug therapy*
  • Remission Induction
  • Treatment Outcome

Substances

  • Melphalan